Covaxin imbroglio: Foreign-bound Indian students agonised over compulsory quarantine, revaccination

​By a staff reporter: Nikhil Patil (21), an engineer from Gujarat’s Vadodara, was relieved when he finally managed to book a Covid 19 vaccination slot for himself after a lot of attempts in May. A few weeks earlier, Patil had secured admission to Canada’s University of Windsor for a post-graduation course and wanted to ensure that he was fully vaccinated by the time he applied for the visa. 

Patil got the first dose of Covaxin and is now anxious about his travel and education like thousands of other foreign-bound students inoculated with it. The vaccine developed by Hyderabad-based Bharat Biotech is yet to get Emergency Use Listing (EUL) approval from the World Health Organisation (WHO). Last week, the latest bid by Bharat Biotech’s US partner Acugen to obtain an emergency-use authorisation was rejected by the US Food and Drug Administration (FDA).

Without WHO approval, most countries are likely to treat those administered Covaxin as unvaccinated. The other vaccine widely in use in the country, Covishield, manufactured by Serum Institute of India, is approved by WHO.

আরও খবরঃ 

https://anmnewsenglish.in/Home/GetNewsDetails?p=1545​For more details visit anmnewsenglish.in
Follow us at https://www.facebook.com/anmnewsEnglish